* Determine the safety and tolerability of hydroxyurea at various doses alone and in combination with ddI. * Compare the short-term antiretroviral effect of hydroxyurea monotherapy vs. hydroxyurea plus ddI as measured by plasma RNA levels at eight weeks of therapy. * Compare the short term antiviral effect of ddI monotherapy versus hydroxyurea plus ddI as measured by plasma RNA levels at eight weeks of therapy.
Showing the most recent 10 out of 563 publications